anmeldenBoston Scientific share#snapshot#suffix
41,17
EUR
+0,87
EUR
+2,15
%
47,82
USD
+0,02
USD
+0,03
%
nachbörslich
Boston Scientific jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 58,59 Mrd. EUR
KGV 49,17 Div. Rendite 0,00%WKN 884113
ISIN US1011371077
Symbol BSX
AI Analyse
Werbung
Boston Scientific Aktie Analyse
| 03.09.19 12:36:08 | Boston Scientific overweight | Barclays Capital | |
| 16.10.18 18:24:56 | Boston Scientific overweight | Barclays Capital | |
| 07.09.18 17:17:33 | Boston Scientific Strong Buy | Needham & Company, LLC | |
| 06.07.18 14:09:53 | Boston Scientific Strong Buy | Needham & Company, LLC | |
| 26.04.18 14:35:01 | Boston Scientific Strong Buy | Needham & Company, LLC | |
| 05.01.18 13:13:22 | Boston Scientific Top Pick | RBC Capital Markets | |
| 08.12.17 13:38:54 | Boston Scientific Strong Buy | Needham & Company, LLC | |
| 30.11.17 12:44:02 | Boston Scientific Buy | BTIG Research | |
|
Werbung
|
|||
| 29.11.17 14:38:19 | Boston Scientific Buy | Canaccord Adams | |
| 24.10.17 15:51:44 | Boston Scientific Buy | Canaccord Adams | |
| 28.06.17 17:25:35 | Boston Scientific overweight | Barclays Capital | |
| 22.06.17 13:23:00 | Boston Scientific Buy | Needham & Company, LLC | |
| 09.06.17 13:17:01 | Boston Scientific Outperform | RBC Capital Markets | |
| 28.04.17 14:18:00 | Boston Scientific Buy | Needham & Company, LLC | |
| 03.02.17 13:52:41 | Boston Scientific Buy | Needham & Company, LLC | |
| 28.04.16 19:22:54 | Boston Scientific overweight | Barclays Capital | |
| 28.04.16 13:41:56 | Boston Scientific Neutral | Wedbush Morgan Securities Inc. | |
| 28.04.16 12:41:58 | Boston Scientific Buy | Stifel, Nicolaus & Co., Inc. | |
| 28.04.16 12:20:34 | Boston Scientific Outperform | RBC Capital Markets | |
| 27.04.16 18:36:52 | Boston Scientific Buy | The Benchmark Company | |
| 12.04.16 12:14:51 | Boston Scientific Outperform | RBC Capital Markets | |
| 28.10.15 18:53:40 | Boston Scientific Buy | Needham & Company, LLC | |
| 28.09.15 13:31:23 | Boston Scientific Buy | Needham & Company, LLC | |
| 23.07.15 19:42:39 | Boston Scientific Buy | The Benchmark Company | |
| 04.05.15 18:32:32 | Boston Scientific Hold | Deutsche Bank AG | |
| 20.04.15 12:44:32 | Boston Scientific Outperform | RBC Capital Markets | |
| 18.02.15 13:23:29 | Boston Scientific Outperform | Oppenheimer & Co. Inc. | |
| 05.02.15 18:25:49 | Boston Scientific Hold | Deutsche Bank AG | |
| 05.02.15 14:28:03 | Boston Scientific Buy | CRT Capital | |
| 05.02.15 13:14:29 | Boston Scientific Buy | Stifel, Nicolaus & Co., Inc. | |
| 30.01.15 19:00:00 | Boston Scientific Outperform | BMO Capital Markets | |
| 30.09.14 13:45:09 | Boston Scientific Hold | Needham & Company, LLC | |
| 07.01.13 12:00:25 | Boston Scientific halten | Deutsche Bank Securities | |
| 29.11.12 17:10:44 | Boston Scientific neutral | UBS AG | |
| 20.11.12 16:56:23 | Boston Scientific buy | Stifel, Nicolaus & Co., Inc. | |
| 20.09.12 10:25:16 | Boston Scientific outperform | RBC Capital Markets | |
| 19.04.12 15:39:59 | Boston Scientific outperform | RBC Capital Markets | |
| 12.03.12 08:47:21 | Boston Scientific outperform | RBC Capital Markets | |
| 06.02.12 16:59:41 | Boston Scientific outperform | RBC Capital Markets | |
| 24.11.11 08:37:19 | Boston Scientific neutral | JP Morgan Chase & Co. | |
| 23.11.11 16:22:24 | Boston Scientific outperform | RBC Capital Markets | |
| 14.11.11 16:38:14 | Boston Scientific outperform | RBC Capital Markets | |
| 21.10.11 16:03:18 | Boston Scientific outperform | RBC Capital Markets | |
| 05.10.11 13:49:40 | Boston Scientific hold | Citigroup Corp. | |
| 22.09.11 16:20:07 | Boston Scientific hold | Kaufman Bros., LP | |
| 14.09.11 15:36:35 | Boston Scientific outperform | RBC Capital Markets | |
| 01.08.11 14:32:53 | Boston Scientific hold | Citigroup Corp. | |
| 24.06.11 17:11:39 | Boston Scientific neutral | UBS AG | |
| 22.06.11 16:47:27 | Boston Scientific buy | Stifel, Nicolaus & Co., Inc. | |
| 13.05.11 14:58:41 | Boston Scientific equal-weight | Barclays Capital | |
Werbung
Werbung
